Showing posts with the label Pharmaceutical

R&D driven Biotechnological Powerhouse Concord Biotech Files DRHP for IPO

Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO Concord Biotech Limi…

Scalable Cell Replacement Therapies Developer Firm Eyestem Raises $6.4 Mn in Series-A Led by Three Pharma Majors

Dr Jogin Desai Founder/CEO with Eyestem Team Eyestem raises Series A round from Biological E, Alkem…

Zeon Lifesciences and Pharma Varsity DPSRU Ink MoU for Innovation in Nutraceuticals, Phytopharmaceuticals and Ayurveda

Zeon Lifesciences signs MoU with Delhi Pharmaceutical Sciences & Research University (DPSRU) Ai…

Combating Counterfeit Drugs Using Blockchain Technology

This content has been authored by Ashwani Kumar , Vice President, Technology at Coforge (Formerly …

Hyderabad-based Biophore to Manufacture Indigenous Ingredients of Pfizer’s COVID Drug

Reduces dependence on China for Indian manufacturers Paxlovid approved by US FDA for COVID treatme…

ENTOD Pharmaceuticals Set to Launch MOLENTOD™ (Molnupiravir), World’s 1st and Only Oral Anti-Viral COVID Treatment

Molnupiravir is the world’s first & only oral antiviral to be approved by the US FDA, UK MHRA &…

IIT Hyderabad Signs Pact with AI-based Drug Discovery Platform PharmCADD for the Co-Development of New Drugs

PharmCADD, a leading in-silico drug design company, and IIT Hyderabad also agreed to promote the a…

Load More That is All